Patent AnalyticsExaminers
Rankings

Company or institution

Numab Therapeutics AG

28 applicationsfiled 2017 to 2025

Allowance rate
86%
+10 pts vs the USPTO range 65% to 95%
Rejections before allowance
1.8
+0.3 vs the USPTO
Months to first action
24.9 mo
+6.3 vs the USPTO
Needed an RCE
24%
−3 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07K Peptides23 apps
A61P Therapeutic activity of compounds5 apps

Art units

16436 apps
OPAP5 apps
16474 apps
16423 apps
16753 apps
16442 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19599520ANTIBODY BINDING DOMAINS HAVING SPECIFICITY FOR LILRB22026-06-19Pending00n/a
19599531MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR CD47 AND PDL12026-06-19Pending00n/a
19421332MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, ANTIBODIES TARGETI…2025-12-16Pending00n/a
15141759Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15499796Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15943387Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15706718Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15828264Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15116450Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15167165Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 28 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in